Company: ELV
Filing Date: 2025-04-22
Form Type: 10-Q
Source: 0001156039-25-000057
Chunk: 41

Company: Elevance Health, Inc.
Filing Date: 2025-04-22
Form: 10-Q
Item: Item 8
Chunk 41
---
 end of 2027 based on results during the three-year period.Fair ValueWe use a binomial lattice valuation model to estimate the fair value of all stock options granted. For a more detailed discussion of our stock incentive plan fair value methodology, see Note 15, “Capital Stock,” to our audited consolidated financial statements as of and for the year ended December 31, 2024 included in Part II, Item 8 of our 2024 Annual Report on Form 10-K. The following weighted-average assumptions were used to estimate the fair values of options granted during the three months ended March 31, 2025 and 2024:Three Months Ended March 3120252024Risk-free interest rate4.29 %4.28 %Volatility factor30.00 %28.00 %Quarterly dividend yield0.432 %0.327 %Weighted-average expected life (years)4.454.40

-28-

The following weighted-average fair values per option or share were determined for the three months ended March 31, 2025 and 2024: Three Months Ended March 3120252024Options granted during the period$107.31 $134.53 Restricted stock awards granted during the period395.49 499.00 Use of Capital – Dividends and Stock Repurchase ProgramWe regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors. A summary of our cash dividend activity for the three months ended March 31, 2025 and 2024 is as follows: Declaration DateRecord DatePayment DateCashDividendper ShareTotalThree Months Ended March 31, 2025January 22, 2025March 10, 2025March 25, 2025$1.71$386 Three Months Ended March 31, 2024January 23, 2024March 8, 2024March 22, 2024$1.63$379 On April 16, 2025, our Audit Committee declared a second quarter 2025 dividend to shareholders of $1.71 per share, payable on June